Harvard Bioscience, Inc. (HBIO)
NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
As of 10:43AM EDT. Market open.
| Previous Close | 3.6800 |
| Open | 3.7000 |
| Bid | 2.6500 x 200 |
| Ask | 4.6800 x 200 |
| Day's Range | 3.6000 - 3.8250 |
| 52 Week Range | 3.4400 - 6.2000 |
| Volume | |
| Avg. Volume | 93,160 |
| Market Cap | 156.317M |
| Beta (5Y Monthly) | 1.46 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.0800 |
| Earnings Date | Aug 06, 2024 - Aug 12, 2024 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 6.92 |
Insider MonkeyHarvard Bioscience, Inc. (NASDAQ:HBIO) Q1 2024 Earnings Call Transcript
Harvard Bioscience, Inc. (NASDAQ:HBIO) Q1 2024 Earnings Call Transcript May 7, 2024 Harvard Bioscience, Inc. misses on earnings expectations. Reported EPS is $-0.10815 EPS, expectations were $0.02. Harvard Bioscience, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good day, […]
- GuruFocus.com
Harvard Bioscience Inc (HBIO) (Q1 2024) Earnings Call Transcript Highlights: Navigating ...
Despite a revenue dip, HBIO maintains robust margins and advances strategic initiatives to bolster future growth.
GuruFocus.comHarvard Bioscience Inc (HBIO) Q1 2024 Earnings: Challenges Persist Amidst Strategic Adjustments
First Quarter Reveals Revenue Decline and Net Loss, Despite Strong Gross Margin
© 2024 Yahoo. All rights reserved.